Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis of new morpholine-benzimidazole-pyrazole hybrids as tubulin polymerization inhibiting anticancer agents
Ravikumar Reddy Sagam, Satheesh Kumar Nukala, Rajkumar Nagavath, et al.
Journal of Molecular Structure (2022) Vol. 1268, pp. 133692-133692
Closed Access | Times Cited: 24

Showing 24 citing articles:

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents
Yingqian Zhang, Chenyuan Wu, Nana Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12724-12724
Open Access | Times Cited: 41
Recent advances on biologically active coumarin-based hybrid compounds
Metin Yıldırım, Samet Poyraz, Mehmet Erşatır
Medicinal Chemistry Research (2023) Vol. 32, Iss. 4, pp. 617-642
Closed Access | Times Cited: 35
Recent developments of benzimidazole based analogs as potential tubulin polymerization inhibitors: A critical review
Rajkumar Reddyrajula, K. Priya Varshini, Nagula Shankaraiah
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130167-130167
Closed Access
An update on the development on tubulin inhibitors for the treatment of solid tumors
Prasanna Anjaneyulu Yakkala, Shaik O. Rahaman, P.S. Lakshmi Soukya, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 3, pp. 193-220
Closed Access | Times Cited: 4
One-pot synthesis, anticancer, EGFR and caspases assays of novel fused [1,2,3]triazolo-pyrrolo[2,1-b]quinazolinones
Narahari Udayasree, Ramesh Babu Haridasyam, Rambabu Palabindela, et al.
Journal of Molecular Structure (2024) Vol. 1320, pp. 139570-139570
Closed Access | Times Cited: 4
Synthesis of Quinoline‐Thiazolidine‐2,4‐dione Coupled Pyrazoles as in vitro EGFR Targeting Anti‐Breast Cancer Agents and Their in silico Studies
Mallikarjuna Bangaru, Satheesh Kumar Nukala, Praveen kumar Kannekanti, et al.
ChemistrySelect (2023) Vol. 8, Iss. 12
Closed Access | Times Cited: 10
Identification of novel 4-thiazolidinones as new TcaR inhibitors: Design, synthesis, molecular docking, MD simulation, ADMET and in vitro antibacterial evaluation
Mahesh D. Vaghasiya, Jigarkumar V. Mendapara, Shaileshkumar P. Vaghasiya, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136308-136308
Closed Access | Times Cited: 10
Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance
Zhengye Liu, Zheng Yang, Mourboul Ablise
Bioorganic Chemistry (2024) Vol. 147, pp. 107310-107310
Closed Access | Times Cited: 3
Design and synthesis of some new imidazole-morpholine-1,2,4-oxadiazole hybrids as EGFR targeting in vitro anti-breast cancer agents
Praveen kumar Kannekanti, Satheesh Kumar Nukala, Srinivas Bandari, et al.
Journal of Molecular Structure (2024) Vol. 1310, pp. 138209-138209
Closed Access | Times Cited: 3
Novel benzimidazolium salts and their silver(I)-N-heterocyclic carbene complexes: synthesis, characterization and their biological properties
Zeyneb Belhi, Hüseyin Karcı, Muhammet Dündar, et al.
Journal of Coordination Chemistry (2023) Vol. 76, Iss. 1, pp. 120-133
Closed Access | Times Cited: 7
Current Development of Pyrazole–Azole Hybrids With Anticancer Potential
Shu Zhang, Yun Ye, Q. Zhang, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 16, pp. 1527-1548
Closed Access | Times Cited: 7
Synthesis of Quinoline‐Morpholine‐Coupled 1,2,3‐Triazole Hybrids as In vitro EGFR inhibitors
Annapurna Mamidala, Karthik Bokkala, Narasimha Swamy Thirukovela, et al.
ChemistrySelect (2022) Vol. 7, Iss. 47
Closed Access | Times Cited: 9
IMesCuCl/TBHP system for aqueous oxidative amidation: Synthesis of new amide derivatives as EGFR targeting anti-breast cancer agents and computational studies
Ravikumar Reddy Sagam, Mohammad Azam, Saud I. Al‐Resayes, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 137922-137922
Closed Access | Times Cited: 1
Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023)
Fatma Fouad Hagar, Samar H. Abbas, Eman Atef, et al.
Molecular Diversity (2024)
Open Access | Times Cited: 1
Benzimidazole‐Containing Compounds as Anticancer Agents
Ulviye Acar Çevik, Ayşen Işık, Betül Kaya, et al.
ChemistrySelect (2024) Vol. 9, Iss. 32
Closed Access | Times Cited: 1
Synthesis, and discovery of a potential anti-HepG2 agents: Coumarin derivatives containing 3-Aryl isoxazolyl moiety
Li-Mei Jia, Shaoling Huang, Wei-Gao Pan, et al.
Journal of Molecular Structure (2023) Vol. 1290, pp. 135892-135892
Closed Access | Times Cited: 3
Ring‐B Modification of Combretastatin A‐4 to Generate Thiazolidine‐2,4‐dione‐1,2,3‐triazole Hybrids as Tubulin Polymerization Inhibitors
Advaitha Vanaparthy, Karthik Bokkala, Narasimha Swamy Thirukovela, et al.
ChemistrySelect (2023) Vol. 8, Iss. 23
Closed Access | Times Cited: 3
Ag(I)-NHC/TBHP promoted aqueous synthesis of some new quinoline-aromatic amides; Anti-proliferative, Anti-VEGFR-2 and Molecular docking studies
Mallikarjuna Bangaru, Satheesh Kumar Nukala, Mohammad Azam, et al.
Journal of Molecular Structure (2024) Vol. 1314, pp. 138664-138664
Closed Access
Antitumor activity and transcriptome sequencing (RNA-seq) analyses of hepatocellular carcinoma cells in response to exposure triterpene-nucleoside conjugates
Qiang Wang, Fangchao Ma, Jingchen Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116635-116635
Closed Access
Current scenario of pyrazole hybrids with anti‐breast cancer therapeutic applications
Mengyu Ma
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access
Organo NHC catalyzed aqueous synthesis of 4β-isoxazole-podophyllotoxins: in vitro anticancer, caspase activation, tubulin polymerization inhibition and molecular docking studies
Rajkumar Nagavath, Murali Krishna Thupurani, Vinitha Badithapuram, et al.
RSC Advances (2024) Vol. 14, Iss. 33, pp. 23574-23582
Open Access
Design and Synthesis of Some New Benzimidazole-1,2,3-triazole-thiazolidine-2,4-dione Conjugates as Tubulin Polymerization Inhibitors
B. Karthik, B. Ramakrishna, B. Ashok Kumar, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 4, pp. 1434-1445
Closed Access
In Vitro Antibreast Cancer and Anti-EGFR Studies of Some Novel Benzimidazole-Piperazine Containing 1,2,3-Triazoles
Prasad Pinnoju, Sadanandam Kudikala, Manasa Scandakashi, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 5, pp. 1724-1734
Closed Access
Programmable C–N Bond Formation through Radical‐Mediated Chemistry in Plasma‐Microdroplet Fusion
Alexander J. Grooms, R. Hüttner, Mackenzie Stockwell, et al.
Angewandte Chemie (2024)
Closed Access
Synthesis of novel imino-coumarin and acrylonitile 2-benzazole hybrids as potent anticancer agents targeting tubulin
Ida Boček, Leentje Persoons, Anja Beč, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107991-107991
Closed Access
Page 1

Scroll to top